Project Grant HT94252310923

Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $2.2M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
This $4,232,760.00 Project Grant, awarded on June 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members and the broader public. The Leland Stanford Junior University, a private research institution, will conduct innovative scientific investigations focused on advancing cure rates for infantile acute lymphoblastic leukemia. The research aims to...
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
This federal Project Grant award of $550,533 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Stanford University to develop a combination treatment of nitazoxanide and auranofin for anaplastic thyroid cancer. The goal of the 2-year project is to transform health care for Service Members and the American public through innovative and impactful research investigating medical solutions for the battlefield. Stanford...
The Department of the Army Medical Command awarded a $750,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant, which runs from September 1, 2024 to August 31, 2027, will fund the implementation of a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. This research, to be conducted at Stanford University, aims to transform...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
The Department of the Army Medical Command awarded a $430,513 Project Grant to The Leland Stanford Junior University (Stanford University) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from March 1, 2025 to February 28, 2027, supports research to understand how vascular endothelial cells regulate fibroblast functions in pancreatitis. Stanford University, a prominent private research institution, has an extensive...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $397,510.00 to The Leland Stanford Junior University (Stanford University) to conduct research on "REVEALING AND TARGETING LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA". The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research, with a focus on cancer therapies. The award...

This Project Grant award of $2,209,988.00 from the Defense Health Agency supports research by The Leland Stanford Junior University, doing business as Stanford University, to develop pharmacological approaches for protection and recovery from burn-associated inhalation injury. The research is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public. Over the award period from September 1, 2023 to August 31, 2026, Stanford University will conduct this research to explore an endogenous airway regenerative pathway as a means of mitigating the effects of burn-associated inhalation injury.

Generated 5/14/24, 5:46 AM